VE
VENAF
MicroAlgo Inc.
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 8, 2026
SEC
Shan Cui filed an initial statement of beneficial ownership (Form 3) with MicroAlgo Inc., reporting zero beneficial owne
3 — Impact 1/10
Apr 1, 2026
SEC
MicroAlgo Inc. reported a 143.5% year-over-year increase in net profit to $18.15 million for fiscal year 2025, driven by
6-K — Impact 6/10
Apr 1, 2026
SEC
MicroAlgo Inc. reported a 22.1% year-over-year decline in revenue for 2025, driven by a comprehensive shift towards cons
20-F — Impact 6/10
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 1 neutral. Avg impact: 4.3/10.
NEUTRAL
3
1/10
Shan Cui filed an initial statement of beneficial ownership (Form 3) with MicroAlgo Inc., reporting
May 8, 2026
MIXED
6-K
6/10
MicroAlgo Inc. reported a 143.5% year-over-year increase in net profit to $18.15 million for fiscal
Apr 1, 2026
MIXED
20-F
6/10
MicroAlgo Inc. reported a 22.1% year-over-year decline in revenue for 2025, driven by a comprehensiv
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.